CTLT Quote, Trading Chart, Catalent Inc.
home / stock / ctlt / ctlt quote
$109.75 Last:
1.05% Change Percent:
$109.11 Open:
$109.75 Previous Close:
$109.86 High:
$107.775 Low:
991,418 Volume:
06/21/2021 04:44:04 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
CTLT Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-21 | 109.11 | 109.75 | 109.86 | 107.775 | 991,418 |
| 2021-06-18 | 109.85 | 108.61 | 110.18 | 108.16 | 1,259,067 |
| 2021-06-17 | 107.54 | 110.56 | 110.73 | 107.515 | 898,485 |
| 2021-06-16 | 108.47 | 107.79 | 109.35 | 107.2 | 713,928 |
| 2021-06-15 | 109.58 | 108.47 | 109.82 | 108.36 | 656,974 |
| 2021-06-14 | 109.16 | 109.58 | 109.8 | 108.92 | 515,625 |
| 2021-06-11 | 109.29 | 109.05 | 109.29 | 107.34 | 496,774 |
| 2021-06-10 | 107.54 | 108.87 | 109.43 | 107.34 | 987,231 |
| 2021-06-09 | 105 | 107.3 | 107.72 | 104.9 | 747,501 |
| 2021-06-08 | 104.9 | 104.12 | 104.9 | 102.7489 | 562,738 |
| 2021-06-07 | 101.26 | 103.92 | 104.24 | 100.9 | 751,529 |
| 2021-06-04 | 101.78 | 101.16 | 102.7 | 100.67 | 1,718,158 |
| 2021-06-03 | 100.37 | 100.61 | 101.18 | 99.03 | 779,784 |
| 2021-06-02 | 102.04 | 100.72 | 102.29 | 100.03 | 1,121,155 |
| 2021-06-01 | 104.97 | 102.01 | 105.23 | 101.96 | 1,539,246 |
| 2021-05-31 | 105.93 | 104.83 | 106.93 | 104.78 | 584,998 |
| 2021-05-28 | 105.93 | 104.83 | 106.93 | 104.78 | 584,998 |
| 2021-05-27 | 104.1 | 105.1 | 105.75 | 103.555 | 1,616,504 |
| 2021-05-26 | 104.05 | 104.29 | 104.92 | 103.55 | 759,379 |
| 2021-05-25 | 102.68 | 103.45 | 104.085 | 102.35 | 712,174 |
Catalent Inc. Company Name:
CTLT Stock Symbol:
NYSE Market:
News, Short Squeeze, Breakout and More Instantly...
-
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that John Chiminski, Chair and Chief Executive Officer, will ...
-
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that members of its executive leadership team will virtually ...
-
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that members of its executive leadership team will virtually ...